Cambridge Biomedical asked by MassBio to help with the new CRO/CMO committee
MassBio has decided that a new group focused on telling the story of the new "super-cluster" of Massachusetts CROs and CMOs - and the value they bring to the biopharma industry - was required. They called on Cambridge Biomedical to help them establish the new CRO/CMO committee and work with them to communicate this message.
The Massachusetts Biotechnology Council (MassBio), is the premier trade organization representing and promoting the Biotechnology and Biopharmaceitucal companies of Massachusetts. MassBio has developed a series of committees to support the needs of said companies and to expand research, development and manufacturing activities of biologics and large molecules.
The mission of the new CRO/CMO committee is to:
Help attract new companies who would establish themselves in the Boston Area, thus creating new jobs
Present outsourcing alternatives, reducing the costss and development timelines for the commercializing of new therapeutics, diagnostics and medical devices
Develop a branding strategy and communicate the ideaof the Mass "super-cluster" and the benefits that are available to working with companies locally
The committee's first symposium will be held on Tuesday, March 6, 2012.
Along with the CRO/CMO comittee, Cambridge Biomedical has been selected by MassBio to participate in the following areas:
1. Drug Discovery Committee => steering committee member
2. MassBio 2012 Design Committee => Design review group of the Bio2012
3. MassBio 2012 Symposium => Accelerating Drug Development Symposium
4. MassBio Annual Meeting Steering Committee